SEC Form 4 · accession 0001246360-16-006027
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel A Giannini
Director
Period of report
May 25, 2016
Accepted (ET)
May 27, 2016 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2016 | M | 14,000 | $18.55 | A | 77,780 | D | |
| Common Stock | May 25, 2016 | F | 13,807 | $18.81 | D | 63,973 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $18.55 | May 25, 2016 | M | 14,000 | D | May 26, 2011 | May 25, 2016 | Common Stock | 14,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $18.32 | May 26, 2016 | A | 15,854 | A | Jun 26, 2016 | May 25, 2023 | Common Stock | 15,854 | 15,854 | D |
Explanation of responses
- F1The stock option becomes exercisable in 12 equal monthly installments beginning June 26, 2016.